Printer Friendly

Nanotech expert joins university directors.

SWANSEA University's Centre for NanoHealth (CNH) has welcomed a new addition to its board of directors.

Professor Huw Summers, current chair of nanotechnology for health and head of the Multidisciplinary Nanotechnology Centre at Swansea University, joins the centre's existing directors Prof Steve Wilks and Prof Steve Conlan, to take CNH into its next phase of development.

The centre, which was established five years ago, combines nanotechnology with medical science to provide opportunities to develop innovative solutions to the challenge of detecting the onset of diseases at the earliest stage.

The centre was built to support companies throughout Wales as well as internationally, and offers a range of services from consultancy, R&D, testing, prototyping to small batch manufacturing.

Prof Summers, who is also a senior affiliate member of the Methodist Hospital Research Institute in Houston, Texas, said: "I am delighted to be appointed as codirector at the Centre for Nano-Health. The centre's multidisciplinary approach is very exciting and enables us to offer companies a one-stop-shop in meeting their business needs.

"The extensive state-of-the-art equipment and facilities, combined with the breath of internationally renowned research expertise available, is hard to match elsewhere."

Prof Summers, who is based within the University's College of Engineering, brings with him an extensive portfolio of experience in business and research excellence.

Over the last 20 years he has been continuously involved with industry. Working in semiconductor optoelectronics, he has been involved in collaborations with Agilent, Sharp Electronics, Motorola and IQE.

More recently Prof Summers has managed medically-related projects in close cooperation with GE Healthcare and Merck Millipore.

For the last four years he has been director of the Swansea Knowledge Transfer Centre in Semiconductors and Photonics, a PS400,000 Welsh Government A4B project, which assisted more than 30 local companies and led to more than PS500m of R&D grant capture plus PS400,000 of commercial investment.

Prof Summers is internationally recognised for his research which focuses on two areas, cell analysis (cytometry) and the development of nanoparticle-based diagnostics and therapeutics (nanomedicine).
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Business
Publication:Western Mail (Cardiff, Wales)
Date:Jan 22, 2014
Previous Article:Expert in birth injury joins JCP Solicitors.
Next Article:Auto Trader equity deal.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters